Annual Long Term Debt
$4.63 M
-$768.00 K-14.23%
December 31, 2024
Summary
- As of March 9, 2025, APVO annual long term debt is $4.63 million, with the most recent change of -$768.00 thousand (-14.23%) on December 31, 2024.
- During the last 3 years, APVO annual long term debt has fallen by -$419.00 thousand (-8.30%).
- APVO annual long term debt is now -79.35% below its all-time high of $22.41 million, reached on December 31, 2020.
Performance
APVO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$4.63 M
-$201.00 K-4.16%
December 31, 2024
Summary
- As of March 9, 2025, APVO quarterly long term debt is $4.63 million, with the most recent change of -$201.00 thousand (-4.16%) on December 31, 2024.
- Over the past year, APVO quarterly long term debt has dropped by -$768.00 thousand (-14.23%).
- APVO quarterly long term debt is now -83.35% below its all-time high of $27.80 million, reached on September 30, 2020.
Performance
APVO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
APVO Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.2% | -14.2% |
| 3 y3 years | -8.3% | -14.2% |
| 5 y5 years | +39.1% | -14.2% |
APVO Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.6% | at low | -47.1% | +19.6% |
| 5 y | 5-year | -79.3% | +39.1% | -83.3% | +62.0% |
| alltime | all time | -79.3% | +39.1% | -83.3% | +62.0% |
Aptevo Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $4.63 M(-14.2%) | $4.63 M(-4.2%) |
| Sep 2024 | - | $4.83 M(-3.9%) |
| Jun 2024 | - | $5.03 M(-3.6%) |
| Mar 2024 | - | $5.21 M(-3.4%) |
| Dec 2023 | $5.40 M(-28.4%) | $5.40 M(-3.2%) |
| Sep 2023 | - | $5.58 M(-3.0%) |
| Jun 2023 | - | $5.75 M(-2.8%) |
| Mar 2023 | - | $5.92 M(-21.5%) |
| Dec 2022 | $7.54 M(+49.3%) | $7.54 M(-7.5%) |
| Sep 2022 | - | $8.15 M(-6.9%) |
| Jun 2022 | - | $8.75 M(+126.1%) |
| Mar 2022 | - | $3.87 M(-23.4%) |
| Dec 2021 | $5.05 M(-77.5%) | $5.05 M(-10.2%) |
| Sep 2021 | - | $5.62 M(-9.2%) |
| Jun 2021 | - | $6.19 M(-8.0%) |
| Mar 2021 | - | $6.73 M(-70.0%) |
| Dec 2020 | $22.41 M | $22.41 M(-19.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $27.80 M(+873.1%) |
| Jun 2020 | - | $2.86 M(-7.8%) |
| Mar 2020 | - | $3.10 M(-6.9%) |
| Dec 2019 | $3.33 M(-82.7%) | $3.33 M(-6.2%) |
| Sep 2019 | - | $3.55 M(-84.8%) |
| Jun 2019 | - | $23.32 M(-0.4%) |
| Mar 2019 | - | $23.41 M(+21.4%) |
| Dec 2018 | $19.28 M(+22.6%) | $19.28 M(+0.7%) |
| Sep 2018 | - | $19.14 M(+24.3%) |
| Jun 2018 | - | $15.40 M(+10.2%) |
| Mar 2018 | - | $13.97 M(-11.1%) |
| Dec 2017 | $15.73 M(-14.4%) | $15.73 M(-10.0%) |
| Sep 2017 | - | $17.48 M(-6.7%) |
| Jun 2017 | - | $18.75 M(+1.7%) |
| Mar 2017 | - | $18.43 M(+0.3%) |
| Dec 2016 | $18.38 M | $18.38 M(+1.5%) |
| Sep 2016 | - | $18.11 M |
FAQ
- What is Aptevo Therapeutics annual long term debt?
- What is the all time high annual long term debt for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual long term debt year-on-year change?
- What is Aptevo Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly long term debt year-on-year change?
What is Aptevo Therapeutics annual long term debt?
The current annual long term debt of APVO is $4.63 M
What is the all time high annual long term debt for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual long term debt is $22.41 M
What is Aptevo Therapeutics annual long term debt year-on-year change?
Over the past year, APVO annual long term debt has changed by -$768.00 K (-14.23%)
What is Aptevo Therapeutics quarterly long term debt?
The current quarterly long term debt of APVO is $4.63 M
What is the all time high quarterly long term debt for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly long term debt is $27.80 M
What is Aptevo Therapeutics quarterly long term debt year-on-year change?
Over the past year, APVO quarterly long term debt has changed by -$768.00 K (-14.23%)